Nano, Candido B.

HRN: 24-47-71  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/04/2024
12/11/2024
IV
4.5g
Q6
SEPSIS SECONDARY TO DECUBITUS ULCER
Waiting Final Action 
12/04/2024
MUPIROCIN 2%, 15G (TUBE)
12/04/2024
12/18/2024
TOPICAL
2%
BID
Decubitus Ulcer
Waiting Final Action 
12/07/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/07/2024
12/14/2024
IV
500mg
Q8h
Septic Encephalopathy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: